Does Ubs own MRNS stock?

As of its Q4 2024 13F, Ubs held 258,944 shares of MRNS (Marinus Pharmaceuticals), worth $138,535.

How many shares of MRNS does Ubs own?

As of its Q4 2024 13F, Ubs held 258,944 shares of MRNS (Marinus Pharmaceuticals).

As of its Q4 2024 13F, Ubs' MRNS position was worth $138,535.

Ubs already held MRNS in its Q3 2020 13F, the earliest on record, and listed it in 18 quarterly 13F filings.

Position history for UBS Group AG's holdings in MARINUS PHARMACEUTICALS INC

Final Value

Final Shares

Total Value Change

-$182,000

Total Shares Change

-14,142

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q1 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q4	Increased	258,944	+114x	$138,535	0.0%	—	24
2024-Q3	Decreased	2,258	-88.1%	$3,974	0.0%	—	0
2024-Q2	Decreased	19,045	-84.6%	$22,283	0.0%	—	0
2024-Q1	Increased	123,852	+49.1%	$1.1M	0.0%	—	35
2023-Q4	Increased	83,070	+48.0%	$902,971	0.0%	—	34
2023-Q3	Increased	56,144	+56.1%	$451,959	0.0%	—	34
2023-Q2	Decreased	35,973	-57.5%	$390,667	0.0%	—	0
2023-Q1	Increased	84,752	+11.8%	$584,789	0.0%	—	27
2022-Q4	Decreased	75,836	-21.3%	$301,827	0.0%	—	0
2022-Q3	Increased	96,375	+0.2%	$641,000	0.0%	—	24
2022-Q2	Increased	96,197	+183.5%	$465,000	0.0%	—	39
2022-Q1	Decreased	33,937	-32.4%	$317,000	0.0%	—	0
2021-Q4	Increased	50,214	+56.3%	$597,000	0.0%	—	35
2021-Q3	Increased	32,118	+4.8%	$366,000	0.0%	—	25
2021-Q2	Increased	30,651	+45.9%	$550,000	0.0%	—	33
2021-Q1	Increased	21,009	+2.0%	$325,000	0.0%	—	24
2020-Q4	Increased	20,597	+45.6%	$252,000	0.0%	—	31
2020-Q3	New	14,142	-	$182,000	0.0%	—	31